Cite

    Kern, P. et al. (n.d.). Neoadjuvant, anthracycline-free chemotherapy with carboplatin and docetaxel in triple-negative, early-stage breast cancer: a multicentric analysis of rates of pathologic complete response and survival. Journal of chemotherapy. pp. 210-217. [Online].